Lexaria Bioscience
Quarterly Financials
| Values in thousands | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 |
|---|---|---|---|---|
Revenue | $0 | $174 | $174 | $174 |
Gross Profit | -24 | 152 | 158 | 156 |
EBITDA | -1,571 | -2,675 | -3,775 | -2,699 |
EBIT | -1,595 | -2,697 | -3,790 | -2,716 |
Net Income | -1,595 | -2,695 | -3,789 | -2,713 |
Net Change In Cash | 0 | 174 | 174 | 174 |
Free Cash Flow | -984 | -2,642 | -3,583 | -1,497 |
Cash | 4,281 | 1,802 | 4,591 | 6,468 |
Basic Shares | 21,376 | 19,559 | 18,298 | 17,511 |
Annual Financials
| Values in thousands | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 |
|---|---|---|---|---|
Revenue | $705 | $464 | $226 | $255 |
Gross Profit | 587 | 383 | 53 | 46 |
EBITDA | -11,795 | -5,732 | -6,567 | -7,236 |
EBIT | -11,911 | -5,808 | -6,712 | -7,383 |
Net Income | -11,901 | -5,795 | -6,664 | -7,269 |
Net Change In Cash | 705 | 464 | 226 | 255 |
Free Cash Flow | -10,475 | -5,002 | -6,050 | -4,928 |
Cash | 1,802 | 6,499 | 1,352 | 5,813 |
Basic Shares | 17,998 | 12,383 | 6,614 | 5,885 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-02-28 | $0 |
2025-11-30 | -$0.10 |
2025-08-31 | -$0.14 |
2025-05-31 | -$0.21 |
